We found, PD mice receiving five days of i.p. L-DOPA+ Benserazide56,156 show reduced percentage of PBMCs expressing DAT and TH (Fig. 3C, E) as compared to saline-treated PD mice. This evidence concerns the gene SLC6A3 and Parkinson disease.